Form 144 ALECTOR For: 26 February

ALECTOR filed a Form 144 with the U.S. Securities and Exchange Commission on February 26, 2026, indicating the company's intention to sell restricted securities. Form 144 filings are notifications made when an insider or large shareholder plans to sell restricted stock that was acquired through compensation or other non-public means. The document, submitted through Investing.com, revealed that ALECTOR, a biotechnology company focused on developing innovative therapies, may be looking to unlock value for shareholders or raise capital for ongoing research and development activities. This regulatory filing comes as ALECTOR continues to advance its pipeline of therapeutic candidates targeting various diseases, with investors closely monitoring any potential stock sales that might indicate insider sentiment or strategic financial moves by the company.